Diabetes Prevention & Weight Loss Drug wrap around care

NHS England is in the tender stage for procuring services under the title "Diabetes Prevention & Weight Loss Drug wrap around care," focusing on health services within the main procurement category of services. This procurement seeks to re-procure the NHS Diabetes Prevention Programme and obtain services to encourage sustained behavioural change for individuals prescribed weight loss drugs. The contract is under the legal framework as per directive 32014L0024 and covers the UK region, involving a significant budget of £383,000,000.

Key upcoming dates include the future notice date set for 31 January 2026. The buying organisation, NHS England, is located in Leeds, UK, and is a body governed by public law. This tender represents a lucrative opportunity for businesses in the health services industry, particularly those specialising in healthcare provision and behavioural change programmes.

Companies with expertise in healthcare interventions, patient support for pharmaceutical treatments, and innovative health service delivery models are well-positioned to compete. The substantial budget highlights the scale of the project, offering potential for considerable business growth and the establishment or expansion of partnerships within the healthcare sector. As the procurement process progresses, competent bidders can leverage this invitation to enter or expand their offerings within the public health service landscape.